www.novonordisk.com.au
Open in
urlscan Pro
149.135.81.59
Public Scan
Submitted URL: http://www.novonordisk.com.au/our-products-for-healthcare-professionals.html
Effective URL: https://www.novonordisk.com.au/our-products-for-healthcare-professionals.html
Submission: On February 06 via api from US — Scanned from AU
Effective URL: https://www.novonordisk.com.au/our-products-for-healthcare-professionals.html
Submission: On February 06 via api from US — Scanned from AU
Form analysis 0 forms found in the DOM
Text Content
Novo Nordisk Australia * Disease areas * Sustainable business * Suppliers & Partners * Careers * About us * * Our products * Contact us * For patients * For healthcare professionals EN EN * Disease areas * Type 1 diabetes * Type 2 diabetes * Obesity * Growth disorders * Haemophilia * Sustainable business * Access & affordability * Zero environmental impact * Preventing chronic diseases * Defeat diabetes * Suppliers & Partners * Purchase order terms & conditions * Careers * Find a job * Job agent * Working at Novo Nordisk * About us * What we do * Who we are * Insulin 100 years * Our heritage * Our scientific approach * Our products * Contact us * For patients * Weekly Insulin and Blood Glucose Record * Frequently Asked Questions * Patient Support Programs * For healthcare professionals Novo Nordisk Australia DISCLAIMER STATEMENT I do not agree I agree WARNING! Ok Cancel OUR PRODUCTS Novo Nordisk has a range of products relating to diabetes, haemostasis, obesity, growth and the menopause. Downloads of the Product Information for these products are available in this section. Written principally for Healthcare Professionals, the Product Information documents provide prescribing information for each of our products. If you are not a Healthcare Professional, Product Information should be read/discussed in consultation with a Healthcare Professional. To view these files you need to have Adobe Acrobat Reader installed. If you do not have Adobe Acrobat Reader you can download the software free of charge. Get Acrobat Reader SEPTEMBER 2023: OZEMPIC® (SEMAGLUTIDE) AVAILABILITY UPDATE Novo Nordisk has advised the TGA there will be continued, limited intermittent availability in Australia of Ozempic® (semaglutide), a medicine approved for use in adults with type 2 diabetes, until December 2024. The reason for the extended intermittent availability is the continued, unprecedented strong demand for Ozempic® (semaglutide) in Australia and around the world. Whilst Ozempic® (semaglutide) supply in Australia improved significantly in 2023, there continues to be strong demand. Novo Nordisk is working hard to satisfy demand to the greatest extent possible. Our deliveries of Ozempic® (semaglutide) to Australia in 2023 were significantly more than compared to 2022 Novo Nordisk continues to expand its global manufacturing capacity to meet the strong demand for Ozempic® (semaglutide) for now and into the future. Our global manufacturing facilities are running 24 hours a day, seven days a week. By the end of 2023, we will have invested more than $US5B in the past two years to open new production lines and facilities. Novo Nordisk, the TGA, AMA, RACGP, Pharmacy Guild and organisations representing diabetes and obesity will continue to work together and will continue to monitor the situation, and provide updated guidance as required It’s important to continue to follow the joint guidance issued by the TGA and various professional bodies on this matter, and additional information about Ozempic® (semaglutide) supply on the TGA website. Novo Nordisk has and will continue to work with the TGA on providing updates on this matter. FREQUENTLY ASKED QUESTIONS If are a healthcare professional and have questions about our products, visit our FAQ page Find out more ACTRAPID® PI Product information ACTRAPID® PENFILL® 3ML Consumer medicine information ACTRAPID® 10ML VIAL Consumer medicine information ESTROFEM® 1MG & 2MG Product information Consumer medicine information FIASP® PI Product information FIASP® FLEXTOUCH® Consumer medicine information FIASP® PENFILL® Consumer medicine information FIASP® 10ML VIAL Consumer medicine information FLEXPEN® User guide GLUCAGEN® HYPOKIT Product information Consumer medicine information INNOLET® User guide KLIOGEST® Product information Consumer medicine information KLIOVANCE® Product information Consumer medicine information LEVEMIR® PI Product information LEVEMIR® FLEXPEN® 3ML Consumer medicine information LEVEMIR® PENFILL® 3ML Consumer medicine information MIXTARD® PI Product information MIXTARD® 30/70 INNOLET® 3ML Consumer medicine information MIXTARD® 30/70 PENFILL® 3ML Consumer medicine information MIXTARD® 50/50 PENFILL® 3ML Consumer medicine information NORDITROPIN® FLEXPRO® PI Product information NORDITROPIN® FLEXPRO® 5MG Consumer medicine information NORDITROPIN® FLEXPRO® 10MG Consumer medicine information NORDITROPIN® FLEXPRO® 15MG Consumer medicine information NOVOMIX® PI Product information NOVOMIX® 30 FLEXPEN® Consumer medicine information NOVOMIX® 30 PENFILL® 3ML Consumer medicine information NOVOPEN® ECHO® User guide NOVOPEN® 4 User guide NOVORAPID® Product information NOVORAPID® FLEXPEN® 3ML Consumer medicine information NOVORAPID® PENFILL® 3ML Consumer medicine information NOVORAPID® 10ML VIAL Consumer medicine information NOVOSEVEN® RT Product information Consumer medicine information NOVOTHIRTEEN® Product information Consumer medicine information OZEMPIC® PI Product information OZEMPIC® 0.25MG, 0.5MG Consumer medicine information OZEMPIC® 1.0 MG Consumer medicine information PROTAPHANE® PI Product information PROTAPHANE® INNOLET® 3ML Consumer medicine information PROTAPHANE® PENFILL® 3ML Consumer medicine information PROTAPHANE® 10ML VIAL Consumer medicine information RYZODEG® 70/30 PI Product information RYZODEG® 70/30 FLEXTOUCH® 3ML Consumer medicine information RYZODEG® 70/30 PENFILL® Consumer medicine information SAXENDA® Product information Consumer medicine information TRISEQUENS® Product information Consumer medicine information VAGIFEM LOW® Product information Consumer medicine information VICTOZA® Product information Consumer medicine information Novo Nordisk Pharmaceuticals Pty Ltd CONTACT US General Enquiries Level 10, 118 Mount Street North Sydney NSW 2060 Phone: +612 8858 3600 Fax: +612 8858 3799 Mail: enquiriesau@novonordisk.com Product Enquiries Reporting Adverse Events NovoCare® Customer Care Centre Phone: 1800 668 626 Fax: +61 2 8858 3697 Mail: aunrccc@novonordisk.com Helpful links Contact us Medicines Australia Report How to report a side effect Business Ethics Code of Conduct Follow us LinkedIn YouTube Facebook X (Twitter) Other offices Select country © 2024 Novo Nordisk Pharmaceuticals Pty Ltd Privacy policy Terms of Use change